Impact of histological subtype on outcomes of renal cell carcinoma patients

Omar Abdel-Rahman
  • Journal of Drug Assessment, January 2018, Taylor & Francis
  • DOI: 10.1080/21556660.2018.1439831

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication

http://dx.doi.org/10.1080/21556660.2018.1439831

The following have contributed to this page: Omar Abdel-Rahman

In partnership with: